Neurocognitive peptides specifically target the brain and nervous system to enhance functions such as memory, focus, mood regulation, and neuroprotection
Availability of telehealth services and prescription products varies by state and jurisdiction and is subject to applicable law and provider licensing
A small clinical trial confirmed these findings, showing that exenatide, another GLP-1 agonist, significantly reduced intracranial pressure in patients with idiopathic intracranial hypertension, greatly improving headache symptoms
Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your current regimen.
31, 2025 (GLOBE NEWSWIRE) -- Truvetas groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has published in JAMA Network Open , offering critical insights into GLP-1 discontinuation and reinitiation rates, and the roles income, adverse events, and weight changes may play